PLGA nanoparticles-based delivery of SRC kinase signaling pathway inhibitor KX2-391 for the treatment of non-alcoholic steatohepatitis

Prize

Description

Poster of distinction. Has received travel award (750 €)
Awarded dateOct 2018
OrganisationsUnited European Gastroenterology (UEG)

Fingerprint

Posters
Fatty Liver
Nanoparticles
Phosphotransferases
N-benzyl-2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)acetamide
polylactic acid-polyglycolic acid copolymer

Documents & Links

Related content

Research Output

PLGA nanoparticles-based delivery of SRC kinase signaling pathway inhibitor KX2-391 for the treatment of non-alcoholic steatohepatitis

Research output: Contribution to conference › Poster › Academic